Table 7.
Comparison of outcome measures using FaCE (total score) and SF-36 (general health subdomain) between first and last visits *.
| FaCE, Total Score | SF-36, General Health | |||||||
|---|---|---|---|---|---|---|---|---|
| First Visit Mean ± SD | Last Visit Mean ± SD | T, df | p | First Visit Mean ± SD | Last Visit Mean ± SD | T, df | p ** | |
| All | 53.8 ± 20.0 | 67.3 ± 20.8 | −15.8, 613 | <0.0001 | 58.4 ± 19.6 | 61.9 ± 21.7 | −3.7, 599 | <0.0001 |
| Glucocorticoids | 60.1 ± 21.5 | 80.8 ± 20.0 | −10.2, 322 | <0.0001 | 59.0 ± 16.7 | 65.0 ± 21.8 | −2.3, 309 | 0.014 |
| Acyclovir | 62.8 ± 19.4 | 83.8 ± 16.9 | −8.0, 158 | <0.0001 | 58.2 ± 17.5 | 65.0 ± 23.4 | −2.3, 140 | 0.028 |
| Glucocorticoids± Acyclovir | 60.5 ± 20.8 | 82.6 ± 17.9 | −8.7, 177 | <0.0001 | 59.6 ± 17.5 | 64.4 ± 22.9 | −2.0, 171 | 0.047 |
| Antibiotics | 53.2 ± 20.5 | 80.7 ± 27.8 | −6.9, 17 | <0.0001 | 54.4 ± 24.1 | 65.4 ± 19.7 | −0.6, 14 | 0.066 |
| Facial nerve reconstruction, any | 54.9 ± 19.3 | 60.6 ± 18.7 | −3.1, 32 | 0.005 | 59.0 ± 24.3 | 61.2 ± 13.5 | −0.5, 26 | 0.601 |
| Facial–facial nerve suture | 70.8 ± 18.5 | 68.1 ± 15.9 | 0.4, 1 | 0.783 | 59.5 ± 10.4 | 53.5 ± 15.6 | 6.0, 1 | 0.105 |
| Facial nerve interpositional graft | 51.7 ± 11.7 | 53.0 ± 8.4 | −0.1, 3 | 0.917 | 64.6 ± 10.4 | 61.5 ± 15.6 | 0.8, 3 | 0.469 |
| Hypoglossal–facial-nerve jump suture | 51.0 ± 18.5 | 59.3 ± 18.2 | −3.1, 28 | 0.005 | 58.6 ± 26.9 | 61.2 ± 14.9 | −0.7, 22 | 0.469 |
| Sling plasty angle of the mouth | 30.0 ± 4.7 | 29.2 ± 8.3 | 0.1, 2 | 0.942 | 42.5 ± 10.6 | 48.5 ± 12.0 | −0.4, 4 | 0.772 |
| Eyelid surgery, any | 46.9 ± 18.1 | 50.7 ± 21.1 | −2.5, 51 | 0.015 | 56.7 ± 23.9 | 54.2 ± 18.3 | 0.9, 47 | 0.390 |
| Upper eyelid weight | 48.1 ± 19.8 | 50.6 ± 23.1 | −2.0, 42 | 0.048 | 54.8 ± 25.4 | 53.8 ± 17.8 | 0.4, 37 | 0.671 |
| Tarsorrhaphy | 41.7 ± 15.0 | 49.7 ± 14.3 | −4.7, 6 | 0.009 | 48.5 ± 19.1 | 53.5 ± 5.0 | −0.3, 6 | 0.818 |
| Kanthopexy | 44.7 ± 17.3 | 39.4 ± 17.2 | 0.9, 5 | 0.422 | 48.5 ± 2.1 | 40.0 ± 0 | 5.7, 5 | 0.111 |
| Brow plasty | 53.0 ± 15.5 | 55.2 ± 20.1 | −0.4, 9 | 0.675 | 54.7 ± 10.8 | 50.7 ± 18.5 | 0.9, 7 | 0.475 |
| Blepharoplasty | 44.9 ± 17.9 | 49.8 ± 23.2 | −1.1, 11 | 0.300 | 57.4 ± 14.1 | 53.0 ± 19.1 | 0.8, 12 | 0.462 |
| Lower lid plasty | 53.0 ± 21.3 | 55.0 ± 25.0 | −0.4, 12 | 0.630 | 54.0 ± 36.2 | 47.3 ± 31.6 | 1.4, 9 | 0.184 |
| Physical therapy/speech therapy | 52.1 ± 20.3 | 62.5 ± 20.3 | −5.9, 61 | <0.0001 | 54.7 ± 14.7 | 55.8 ± 12.5 | −0.2, 56 | 0.586 |
| Electrotherapy | 45.5 ± 18.1 | 54.4 ± 20.6 | −4.7, 45 | <0.0001 | 56.0 ± 18.8 | 57.1 ± 21.8 | −0.4, 44 | 0.715 |
| Botulinumtoxin injection | 50.5 ± 19.7 | 61.1 ± 17.1 | −6.5, 110 | <0.0001 | 53.7 ± 20.2 | 62.1 ± 23.4 | −1.9, 84 | <0.0001 |
| Eye moisture chamber | 57.4 ± 22.2 | 78.7 ± 22.2 | −9.2, 73 | <0.0001 | 58.5 ± 18.3 | 66.5 ± 22.8 | −2.6, 69 | 0.013 |
| Eye drops/ointment | 57.2 ± 21.4 | 77.6 ± 22.3 | −10.0, 108 | <0.0001 | 59.4 ± 17.4 | 66.6 ± 22.9 | −1.9, 107 | 0.020 |
| Facial exercises at home | 63.3 ± 18.5 | 81.6 ± 18.5 | −7.4, 72 | <0.0001 | 59.5 ± 16.8 | 64.7 ± 22.8 | −1.8, 60 | 0.076 |
| Facial EMG biofeedback training | 52.0 ± 17.9 | 63.9 ± 16.6 | −10.7, 190 | <0.0001 | 61.2 ± 21.6 | 61.5 ± 19.2 | −0.9, 127 | 0.932 |
* n = 1073 patients with at least two visits; ** significant p-values (p < 0.05) in bold; paired t-test; FaCE = Facial Clinimetric Evaluation Scale; SF-36 = 36-Item Short Form Survey; NA = not applicable; SD = standard deviation.